Judges in Amsterdam have rejected a claim for collective damages against pharmaceutical company Allergan, now part of AbbVie, over the health risks linked to its textured breast implants. The case was ...

In quick succession for opioid settlements, AbbVie’s Allergan unit has agreed to fork over more than $2 billion to resolve the thousands of lawsuits regarding the marketing of its opioid painkiller, ...

AbbVie’s cosmetics and skin care company Allergan Aesthetics is building on its long-term partnership with nonprofit Girls Inc. to further invest in women’s career trajectories in the Science, ...

DUBLIN, Oct. 7, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in eye care, today announced the launch of three new ...

SAN DIEGO, Sept. 13, 2010 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit has been filed by an Allergan investor in State Court against members of Allergan's board in ...

AGN-151587 (EDIT-101) is the first in vivo CRISPR medicine to be administered to patients Additional patient enrollment to the BRILLIANCE Clinical Trial is ongoing DUBLIN, Ireland and CAMBRIDGE, Mass.

Allergan is looking into strategic options for its women’s heath unit amid a financial slump driven by heightened competition for its best-selling skin and eye drugs, unnamed sources told Bloomberg.

Allergan Aesthetics launched its SkinMedica Even & Correct Collection Tuesday morning, featuring a suite of products targeting hyperpigmentation. The company noted that these SkinMedica offerings are ...

(Reuters) - Allergan Plc would pay $750 million to settle a class action lawsuit from a group of direct purchasers of Alzheimer's disease therapy Namenda, the drugmaker said, in a resolution to the ...

Allergan Inc., maker of Botox and other drugs, has filed plans with Irvine officials to build a 250,000-square-foot, four-story office tower at its campus near John Wayne Airport. Allergan spokeswoman ...

Allergan Inc.’s deep-rooted eye drugs are holding their own in a company where breast implants and wrinkle removers have grabbed most of the attention of late. The Irvine drug maker’s first-quarter ...

NEW YORK (Reuters) - Purchasers of Allergan Plc's Namenda asked a federal judge on Tuesday to approve a $750 million settlement of claims that the drugmaker conspired to keep generic versions of the ...